Literature DB >> 24265979

Bacteriophage K for reduction of Staphylococcus aureusbiofilm on central venous catheter material.

Matthew P Lungren1, Diana Christensen, Ravi Kankotia, Irene Falk, Ben E Paxton, Charles Y Kim.   

Abstract

The purpose of this project was to determine whether bacteriophage can reduce bacterial colonization and biofilm formation on central venous catheter material. Twenty silicone discs were inoculated for 24 h with broth culture of Methicillin sensitive staphylococcus aureus (0.5 McFarland standard). The inoculate was aspirated and discs placed into two equal groups for 24 h: (1) untreated controls; (2) bacteriophage treatment (staphylococcal bacteriophage K, propagated titer > 108). At the completion of the experiment discs were processed for quantitative culture. Statistical testing was performed using the rank sum test. Mean colony forming units (CFU) were significantly decreased in experimental compared with controls (control 6.3 × 105 CFU, experimental 6.7 × 101, P ≤ 0.0001). Application of bacteriophage to biofilm infected central venous catheter material significantly reduced bacterial colonization and biofilm presence. Our data suggests that bacteriophage treatment may be a feasible strategy for addressing central venous catheter staph aureus biofilm infections.

Entities:  

Keywords:  bacteriophage k; biofilm; central venous catheters; phage therapy; staph aureus

Year:  2013        PMID: 24265979      PMCID: PMC3829956          DOI: 10.4161/bact.26825

Source DB:  PubMed          Journal:  Bacteriophage        ISSN: 2159-7073


  27 in total

Review 1.  Bacteriophage therapy of bacterial infections: an update of our institute's experience.

Authors:  B Weber-Dabrowska; M Mulczyk; A Górski
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2000       Impact factor: 4.291

Review 2.  Antibiotic lock technique: review of the literature.

Authors:  Megan B Bestul; Heather L Vandenbussche
Journal:  Pharmacotherapy       Date:  2005-02       Impact factor: 4.705

Review 3.  Phage therapy in clinical practice: treatment of human infections.

Authors:  Elizabeth Kutter; Daniel De Vos; Guram Gvasalia; Zemphira Alavidze; Lasha Gogokhia; Sarah Kuhl; Stephen T Abedon
Journal:  Curr Pharm Biotechnol       Date:  2010-01       Impact factor: 2.837

4.  Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution.

Authors:  Zipporah Krishnasami; Donna Carlton; Lisa Bimbo; Maria E Taylor; Daniel F Balkovetz; Jill Barker; Michael Allon
Journal:  Kidney Int       Date:  2002-03       Impact factor: 10.612

5.  Using bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis.

Authors:  John J Curtin; Rodney M Donlan
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

6.  Lack of antimicrobial activity of sodium heparin for treating experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique.

Authors:  J A Capdevila; J Gavaldà; J Fortea; P López; M T Martin; X Gomis; A Pahissa
Journal:  Clin Microbiol Infect       Date:  2001-04       Impact factor: 8.067

7.  Susceptibility of Staphylococcus epidermidis planktonic cells and biofilms to the lytic action of staphylococcus bacteriophage K.

Authors:  N Cerca; R Oliveira; J Azeredo
Journal:  Lett Appl Microbiol       Date:  2007-09       Impact factor: 2.858

8.  Antimicrobial and antibiofilm efficacy of triclosan and DispersinB combination.

Authors:  Rabih O Darouiche; Mohammad D Mansouri; Purushottam V Gawande; Srinivasa Madhyastha
Journal:  J Antimicrob Chemother       Date:  2009-05-14       Impact factor: 5.790

9.  Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system.

Authors:  Weiling Fu; Terri Forster; Oren Mayer; John J Curtin; Susan M Lehman; Rodney M Donlan
Journal:  Antimicrob Agents Chemother       Date:  2009-10-12       Impact factor: 5.191

10.  Biofilm formation and effect of caspofungin on biofilm structure of Candida species bloodstream isolates.

Authors:  J A G Ferreira; J H Carr; C E F Starling; M A de Resende; R M Donlan
Journal:  Antimicrob Agents Chemother       Date:  2009-06-22       Impact factor: 5.191

View more
  8 in total

1.  Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens.

Authors:  Erin E Gill; Octavio L Franco; Robert E W Hancock
Journal:  Chem Biol Drug Des       Date:  2015-01       Impact factor: 2.817

Review 2.  Staphylococcal Biofilms.

Authors:  Michael Otto
Journal:  Microbiol Spectr       Date:  2018-08

3.  Antimicrobial effect of commercial phage preparation Stafal® on biofilm and planktonic forms of methicillin-resistant Staphylococcus aureus.

Authors:  Milada Dvořáčková; Filip Růžička; Martin Benešík; Roman Pantůček; Monika Dvořáková-Heroldová
Journal:  Folia Microbiol (Praha)       Date:  2018-06-20       Impact factor: 2.099

4.  Nonconventional Therapeutics against Staphylococcus aureus.

Authors:  Caroline M Grunenwald; Monique R Bennett; Eric P Skaar
Journal:  Microbiol Spectr       Date:  2018-11

5.  Characterization and partial genomic analysis of a lytic Myoviridae bacteriophage against Staphylococcus aureus isolated from dairy cows with mastitis in Mid-east of China.

Authors:  Lili Zhang; Hongduo Bao; Chengrui Wei; Hui Zhang; Yan Zhou; Ran Wang
Journal:  Virus Genes       Date:  2014-10-21       Impact factor: 2.332

Review 6.  Ecology of Anti-Biofilm Agents II: Bacteriophage Exploitation and Biocontrol of Biofilm Bacteria.

Authors:  Stephen T Abedon
Journal:  Pharmaceuticals (Basel)       Date:  2015-09-09

7.  Strain Specific Phage Treatment for Staphylococcus aureus Infection Is Influenced by Host Immunity and Site of Infection.

Authors:  Nathan B Pincus; Jensen D Reckhow; Danial Saleem; Momodou L Jammeh; Sandip K Datta; Ian A Myles
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

8.  Effects of Staphylococcus aureus Bacteriophage K on Expression of Cytokines and Activation Markers by Human Dendritic Cells In Vitro.

Authors:  Helen R Freyberger; Yunxiu He; Amanda L Roth; Mikeljon P Nikolich; Andrey A Filippov
Journal:  Viruses       Date:  2018-11-08       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.